Clinical Trial Update: Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry reports the completion of a Phase 1 study evaluating the iodine-131 labeled monoclonal antibody TNT-1/B for progressive or recurre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• TNT-1/B (Iodine-131 labeled monoclonal antibody) (TNT-1/B)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED